Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.61K | Sales 2023 | 555 366.67 | Capitalization | 39.72M 26.24M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.86M | Net income 2023 | -20M -13.21M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.86M | Net cash position 2023 | 3.44M 2.28M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.68% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |